VLA
Click for more information
0.00% $1.75 viralytics limited

A cynic might argue that a pharma with a somewhat inferior...

  1. LongNow
    1,365 Posts.
    clock Created with Sketch.
    30/01/15
    13:41
    Post #: 14667779

    A cynic might argue that a pharma with a somewhat inferior product would be willing to pay more for a drug which leapfrogged their competition, than a market leader would pay to extend their advantage.
    VLA Price at posting: 31.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Exceptional test at Erregulla Deep-1 delivers strong flow rates with high pressure, indicating potential for greater output
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
NEWS What's causing the cost-of-living crisis, and how to navigate it
right-arrow Created with Sketch.
NEWS Elixir signs MOU with AGIG to explore gas infrastructure development for Taroom Trough project
right-arrow Created with Sketch.
NEWS Drilling confirms large-scale gold-copper system at Kaa Prospect in Queensland, with mineralisation open in all directions
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.